Pfizer is expected to discuss its plans for dealing with a shrinking product line as some of its key patents expire.
MarketWatch.com - Top Stories, MarketWatch
Mon, 04/27/2015 - 2:55pm
Pfizer is expected to discuss its plans for dealing with a shrinking product line as some of its key patents expire.